These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 19349195)
1. Identification and characterization of human ARIP2 and its relation to breast cancer. Li ZD; Wu Y; Bao YL; Yu CL; Guan LL; Wang YZ; Meng XY; Li YX Cytokine; 2009 May; 46(2):251-9. PubMed ID: 19349195 [TBL] [Abstract][Full Text] [Related]
2. Characterization of isoforms of activin receptor-interacting protein 2 that augment activin signaling. Liu ZH; Tsuchida K; Matsuzaki T; Bao YL; Kurisaki A; Sugino H J Endocrinol; 2006 May; 189(2):409-21. PubMed ID: 16648306 [TBL] [Abstract][Full Text] [Related]
3. Novel factors in regulation of activin signaling. Tsuchida K; Nakatani M; Matsuzaki T; Yamakawa N; Liu Z; Bao Y; Arai KY; Murakami T; Takehara Y; Kurisaki A; Sugino H Mol Cell Endocrinol; 2004 Oct; 225(1-2):1-8. PubMed ID: 15451561 [TBL] [Abstract][Full Text] [Related]
4. Regulation of endocytosis of activin type II receptors by a novel PDZ protein through Ral/Ral-binding protein 1-dependent pathway. Matsuzaki T; Hanai S; Kishi H; Liu Z; Bao Y; Kikuchi A; Tsuchida K; Sugino H J Biol Chem; 2002 May; 277(21):19008-18. PubMed ID: 11882656 [TBL] [Abstract][Full Text] [Related]
5. Expression and localization of activin receptor-interacting protein 2 in mouse tissues. Liu HY; Chen FF; Ge JY; Wang YN; Zhang CH; Cui XL; Yu F; Tai GX; Liu ZH Gen Comp Endocrinol; 2009 Apr; 161(2):276-82. PubMed ID: 19523381 [TBL] [Abstract][Full Text] [Related]
6. Effects of activin A on the activities of the mouse peritoneal macrophages. Zhang XJ; Li Y; Tai GX; Xu GY; Zhang PY; Yang Y; Lao FX; Liu ZH Cell Mol Immunol; 2005 Feb; 2(1):63-7. PubMed ID: 16212913 [TBL] [Abstract][Full Text] [Related]
7. Regulation of activin receptor-interacting protein 2 expression in mouse hepatoma Hepa1-6 cells and its relationship with collagen type IV. Zhang HJ; Tai GX; Zhou J; Ma D; Liu ZH World J Gastroenterol; 2007 Nov; 13(41):5501-5. PubMed ID: 17907296 [TBL] [Abstract][Full Text] [Related]
8. hARIP2 is a putative growth-promoting factor involved in human colon tumorigenesis. Gao RF; Li ZD; Jiang J; Yang LH; Zhu KT; Lin RX; Li H; Zhao Q; Zhang NS Asian Pac J Cancer Prev; 2014; 15(20):8581-6. PubMed ID: 25374171 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of activin on the growth and morpholgenesis of primary and transformed mammary epithelial cells. Liu QY; Niranjan B; Gomes P; Gomm JJ; Davies D; Coombes RC; Buluwela L Cancer Res; 1996 Mar; 56(5):1155-63. PubMed ID: 8640777 [TBL] [Abstract][Full Text] [Related]
10. Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines. Jeffery PL; Murray RE; Yeh AH; McNamara JF; Duncan RP; Francis GD; Herington AC; Chopin LK Endocr Relat Cancer; 2005 Dec; 12(4):839-50. PubMed ID: 16322325 [TBL] [Abstract][Full Text] [Related]
11. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1. Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233 [TBL] [Abstract][Full Text] [Related]
12. Dissociation of angiogenesis and tumorigenesis in follistatin- and activin-expressing tumors. Krneta J; Kroll J; Alves F; Prahst C; Sananbenesi F; Dullin C; Kimmina S; Phillips DJ; Augustin HG Cancer Res; 2006 Jun; 66(11):5686-95. PubMed ID: 16740706 [TBL] [Abstract][Full Text] [Related]
13. Alantolactone inhibits cell proliferation by interrupting the interaction between Cripto-1 and activin receptor type II A in activin signaling pathway. Shi Y; Bao YL; Wu Y; Yu CL; Huang YX; Sun Y; Zheng LH; Li YX J Biomol Screen; 2011 Jun; 16(5):525-35. PubMed ID: 21378277 [TBL] [Abstract][Full Text] [Related]
14. The autocrine effect of activin A on human ovarian clear cell adenocarcinoma cells. Mabuchi Y; Yamoto M; Minami S; Umesaki N Oncol Rep; 2006 Aug; 16(2):373-9. PubMed ID: 16820918 [TBL] [Abstract][Full Text] [Related]
15. Bridge-1 is expressed in human breast carcinomas: silencing of Bridge-1 decreases Smad2, Smad3 and Smad4 expression in MCF-7 cells, a human breast cancer cell line. Banz-Jansen C; Münchow B; Diedrich K; Finas D Arch Gynecol Obstet; 2011 Dec; 284(6):1543-9. PubMed ID: 21448710 [TBL] [Abstract][Full Text] [Related]
16. SMILE, a new orphan nuclear receptor SHP-interacting protein, regulates SHP-repressed estrogen receptor transactivation. Xie YB; Lee OH; Nedumaran B; Seong HA; Lee KM; Ha H; Lee IK; Yun Y; Choi HS Biochem J; 2008 Dec; 416(3):463-73. PubMed ID: 18657049 [TBL] [Abstract][Full Text] [Related]
17. Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Schnelzer A; Prechtel D; Knaus U; Dehne K; Gerhard M; Graeff H; Harbeck N; Schmitt M; Lengyel E Oncogene; 2000 Jun; 19(26):3013-20. PubMed ID: 10871853 [TBL] [Abstract][Full Text] [Related]
18. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer. Li HZ; Gao Y; Zhao XL; Liu YX; Sun BC; Yang J; Yao Z Mol Cancer Res; 2009 Jun; 7(6):832-40. PubMed ID: 19531568 [TBL] [Abstract][Full Text] [Related]
19. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells. Neubauer H; Adam G; Seeger H; Mueck AO; Solomayer E; Wallwiener D; Cahill MA; Fehm T Climacteric; 2009 Jun; 12(3):230-9. PubMed ID: 19340614 [TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells. Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]